These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 232916)

  • 1. Renal osteopenia - an assessment of long-term therapy with vitamin D analogues.
    Catto GR; Junor BJ; Fraser RA; Smith FW; Ettinger KV; Edward N; MacLeod M
    Proc Eur Dial Transplant Assoc; 1979; 16():637-43. PubMed ID: 232916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis osteodystrophy. A study involving 94 patients.
    Chan YL; Furlong TJ; Cornish CJ; Posen S
    Medicine (Baltimore); 1985 Sep; 64(5):296-309. PubMed ID: 3839891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
    Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
    J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of renal osteodystrophy following renal transplantation.
    Pierides AM; Ellis HA; Peart KM; Simpson W; Uldall PR; Kerr DN
    Proc Eur Dial Transplant Assoc; 1975; 11():481-7. PubMed ID: 1105559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy.
    Chesney RW; Moorthy AV; Eisman JA; Jax DK; Mazess RB; DeLuca HF
    N Engl J Med; 1978 Feb; 298(5):238-42. PubMed ID: 201843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone disease in long-term haemodialysis: the association of radiological with histological abnormalities.
    Simpson W; Ellis HA; Kerr DN; McElroy M; McNay RA; Ppeart KN
    Br J Radiol; 1976 Feb; 49(578):105-10. PubMed ID: 938826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
    Pierides AM; Ellis HA; Simpson W; Dewar JH; Ward MK; Kerr DN
    Lancet; 1976 May; 1(7969):1092-5. PubMed ID: 57505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
    Orwoll ES; Meier DE
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone histology in patients with nephrotic syndrome and normal renal function.
    Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
    Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
    Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
    Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG; Nielsen LP; Mogensen NB
    Nephron; 1983; 35(2):103-7. PubMed ID: 6621754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral and bone metabolism in thyroid disease: a review.
    Auwerx J; Bouillon R
    Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A
    Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone and mineral metabolism and chronic alcohol abuse.
    Lalor BC; France MW; Powell D; Adams PH; Counihan TB
    Q J Med; 1986 May; 59(229):497-511. PubMed ID: 3763813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.